Cabinet to decide on cannabis-linked vape production by US firm, says Dzulkefly
According to an investor presentation in Las Vegas in April, Ispire Technology Inc produces 'mainly cannabis-related products' in its Malaysian manufacturing facility. (LinkedIn pic)
KUALA LUMPUR : The fate of a US-based vape manufacturer producing cannabis-related products in Malaysia will be decided by the Cabinet, says health minister Dzulkefly Ahmad.
Speaking on the sidelines of the APHM International Healthcare Conference & Exhibition 2025, Dzulkefly said the issue involving Ispire Technology Inc would require the input of several ministries and government agencies.
'I will have to present (the matter) to the Cabinet. From there, we will decide on a stance.
'Several bodies are involved in this issue such as the investment, trade and industry ministry, the Malaysian Investment Development Authority, and the domestic trade and cost of living ministry,' he told reporters.
Health think tank CodeBlue recently reported that Ispire, which produces nicotine and cannabis-related vaping products, had said that its devices were used by clients to fill cartridges with cannabis oils in global markets.
According to an investor presentation in Las Vegas in April published on YouTube on May 6, Ispire produces 'mainly cannabis-related products' in its Malaysian manufacturing facility, which has up to seven production lines.
In a statement last week, the health ministry confirmed that the government had issued Ispire an interim nicotine manufacturing licence to produce e-cigarettes with nicotine in its plant in Johor, together with local council approval.
However, CodeBlue noted that the ministry's June 2 statement did not mention the plant's production of cannabis vaporisers, which reportedly began in February 2024.
On June 5, Kuala Langat MP Dr Ahmad Yunus Hairi called for a police investigation into the vape factory's operations.
GP consultation fee revision
Separately, Dzulkefly said his ministry had submitted its plans to the National Action Council on Cost of Living to address the long-standing issue of revising general practitioner (GP) consultation fees.
'The council has requested that the matter be brought to its executive committee, which is chaired by deputy prime minister Ahmad Zahid Hamidi.
'There is no fixed date for discussions yet, but it will be soon,' he added.
Yesterday, the Medical Practitioners Coalition Association of Malaysia (MPCAM) warned the government against deregulating GP consultation fees without setting a minimum rate.
MPCAM president Dr Soo Tai Kang said such a move would lead to unhealthy competition in the industry, particularly in urban areas where 80% of GP clinics operate and depend heavily on panel patients.
Soo said MPCAM supported setting consultation fees at between RM50 and RM80, with reviews every three years.
On June 5, the Malaysian Medical Association called on the government to approve a long-pending increase in GP consultation fees, warning that delays threatened the survival of primary care clinics nationwide.
Dzulkefly said on May 3 that the matter would be resolved 'within one month', and that a Cabinet memorandum and circular had already been prepared.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
an hour ago
- Malay Mail
Kenanga Investors Recognised At The Global Islamic LSEG Lipper Fund Awards 2025 For Shariah-Compliant Excellence
Datuk Wira Ismitz Matthew De Alwis, Executive Director and Chief Executive Officer of Kenanga Investors Berhad KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 9 June 2025 - Kenanga Investors Berhad ("") has received international recognition for the Kenanga SyariahEXTRA Fund ("") which was awarded under the Mixed Asset MYR Balanced 10 Years category at the. The KSEF recently won the Best Mixed Asset MYR Balanced – Malaysia Islamic Funds Awards Over 10 Years title at the. This recognition further affirms Kenanga Investors' standing as a leading global asset and wealth management Wira Ismitz Matthew De Alwis, Executive Director and Chief Executive Officer said, "We are pleased that the Kenanga SyariahEXTRA Fund has received its second Lipper recognition in a year for its impressive performance. Shariah-compliant funds have seen increased interest, partly due to inclination toward defensive sectors like healthcare, telecommunications, and utilities, which tend to be more resilient during market downturns, making them attractive to both Muslim and non-Muslim investors seeking resilience amid market uncertainty. The Fund exemplifies our commitment to investing for good, blending Shariah principles with the benefits of impact investing. By focusing on sectors that align with both ethical values and long-term sustainability, we strive to deliver strong returns for our investors while contributing to meaningful, positive at 31st March 2025, the KSEF delivered returns of 46.30%* (5-years), 62.85%* (10-years), 220.02%* (since inception). Launched in 1996, KSEF aims to provide investors with medium to long-term capital appreciation through investments in specified asset classes by adopting a balanced approach towards equities and fixed income exposure based on Shariah Sook Yee, the Chief Investment Officer of Kenanga Investors explained, "The KSEF's outperformance is mainly attributed to Shariah-compliant stock, sukuk selection and asset allocation. The team continued the strategy of identifying key sectors or groups of Shariah-compliant securities that we believe would perform well under an anticipated economic condition. Individual Shariah-compliant securities selection will then focus on well-managed, financially sound companies with attractive relative valuations and a potential for high earnings growth over the medium to long term time frame. We believe in staying consistent with our investment philosophy so that we may manage our portfolios effectively to capitalise on market opportunities, even with volatility".The firm recently saw its innovative efforts within the Shariah investing landscape recognised at thewhich awarded its exchange-traded funds' arm, Eq8 Capital Sdn Bhd with the Special Award – Thought Leadership for launching Eq8 FTSE Malaysia Enhanced Dividend Waqf ETF, the world's first Waqf-featured Exchange Traded Fund. The Waqf ETF aims to distribute income annually with half of the income distribution to be allocated as Waqf assets with the remaining half payable to Global Islamic LSEG Lipper Fund Awards celebrate funds and fund management firms that have delivered consistently strong risk-adjusted performance relative to more information about Kenanga Investors, please visit *Source: Lipper Investment Analytics, 31 March #Kenanga The issuer is solely responsible for the content of this announcement. Kenanga Investors Berhad 199501024358 (353563-P) We provide investment solutions ranging from collective investment schemes, portfolio management services, alternative investments, as well as wills and trusts for retail, corporate, institutional, and high net worth clients via a multi-distribution network. The Morningstar Award 2025 has recognised the Kenanga Blue Chip Fund as Best Malaysia Large-Cap Equity Fund. The Bursa Excellence Awards 2024 awarded KIB's exchange-traded funds' arm, Eq8 Capital Sdn Bhd with the Special Award – Thought Leadership for launching Eq8WAQF, the world's first Waqf-featured Exchange Traded Fund. Introduced under a newly established category, the award highlights innovations that are reshaping the investment landscape. At the LSEG Lipper Fund Awards Malaysia 2025, KIB received awards for the Kenanga DividendEXTRA Fund ("KDEF") under the Best Equity Malaysia Diversified – Malaysia Funds over 3 years, Kenanga Malaysian Inc Fund ("KMIF") under the Best Equity Malaysia Diversified – Malaysia Provident Funds over 10 years, Kenanga Balanced Fund ("KBF") under the Best Mixed Asset MYR Balanced – Malaysia Provident Funds over 10 years, Kenanga Managed Growth Fund ("KMGF") under Best Mixed Asset MYR Flexible – Malaysia Provident Funds over 10 years, and Kenanga SyariahEXTRA Fund ("KSEF") under the Best Mixed Asset MYR Balanced – Malaysia Islamic Funds Awards over 10 years. The Hong Kong-based Asia Asset Management's 2025 Best of the Best Awards awarded KIG under the following categories, Malaysia Best Impact Investing Manager, Best Impact Investing Manager in ASEAN, Malaysia Best Equity Manager, Malaysia CEO of the Year (Co-Winner), Malaysia CIO of the Year, Malaysia Best House for Alternatives, Malaysia Best ESG Engagement Initiative, Malaysia Fund Launch of the Year, and Malaysia Best Retail Asset Management Company. The FSMOne Recommended Unit Trusts Awards 2024/2025 has awarded the Kenanga Growth Fund Series 2 with the "Sector Equity – Malaysia Focused" award for the third consecutive year since 2022. We were also recognised at The BrandLaureate BestBrands Awards 2024 - Brand of the Year under the category Wealth Management & Investment Solutions. For the eighth consecutive year, KIB was affirmed an investment manager rating of IMR-2 by Malaysian Rating Corporation Berhad, since first rated in 2017. The IMR rating on KIB reflects the fund management company's well-established investment processes and sound risk management practices. This Press Release was issued by Kenanga Group's Marketing, Communications & Sustainability department.
New Straits Times
an hour ago
- New Straits Times
APHM offers clinical data to support DRG system pricing rollout
KUALA LUMPUR: Member hospitals under the Association of Private Hospitals Malaysia (APHM) have offered to share clinical data essential for developing the Diagnostic-Related Group (DRG) pricing model. In a statement today, APHM said its member hospitals will provide the relevant data to the Health and Finance Ministries, as this foundational data is currently unavailable and poses significant challenges to the timely and effective implementation of the DRG system. "APHM is heartened to hear (Health Minister) Datuk Seri Dr Dzulkefly Ahmad shared in his opening speech at the APHM International Healthcare Conference & Exhibition 2025 today that a basic medical and takaful health insurance product will be introduced this year, while the DRG will be rolled out in phases. "For the DRG or any DRG-type mechanism to work, accurate clinical data and a national electronic health record system are needed. "At present, this foundational data is not yet available, which presents significant challenges for timely and effective DRG implementation," it said. APHM said implementing the DRG system properly will take more than six months, as the data collection and analysis process is both complex and time-consuming. The association also advocates allocating sufficient time and resources to ensure that the DRG model is well conceptualised, thoroughly piloted, and effectively executed to bring long-term improvements to Malaysia's healthcare system. On April 18, Dzulkefly said the ministry plans to implement the DRG syste m in stages this year, starting with common illnesses. On April 21, APHM's president Datuk Dr Kuljit Singh said the DRG pricing model presents a major challenge for Malaysia, primarily due to the lack of a universal healthcare financing system. The DRG model is a billing system under which hospitals charge a fixed fee for treating specific illnesses or conditions, aimed at curbing medical inflation.
The Star
an hour ago
- The Star
Proper DRG roll out can take more than six months, says private hospitals association
KUALA LUMPUR: A proper rollout of the diagnosis-related group (DRG) payment model could take more than six months given the complexities in data gathering and analysis, says the Association of Private Hospitals Malaysia (APHM), adding that it is ready to provide any help. Its president Datuk Dr Kuljit Singh said accurate clinical data and a national electronic health record system is needed for any DRG-type mechanism to work He said this foundational data is not available yet. "As the process of gathering and analysing such data is complex and time-consuming, APHM anticipates that a proper rollout will require considerably more than six months," he said. Dr Kuljit also said the APHM welcomed Health Minister Datuk Seri Dr Dzulkefly Ahmad's announcement that a basic medical and health insurance/takaful product would be introduced later this year and the DRG rolled out in phases. To support this national initiative, Dr Kuljit said APHM member hospitals have offered to share relevant clinical data with the Health Ministry and the Finance Ministry. "APHM strongly advocates that adequate time and resources are allocated to ensure that the DRG initiative is thoroughly conceptualised, piloted and implemented, to ultimately deliver sustainable improvements for all Malaysians," he said. The DRG payment system involves paying a fixed sum based on the diagnosis and treatment provided, rather than itemising each charge. It is said the DTG model can help regulate medical costs by limiting excessive charges. Examples of countries that have implemented this are Sweden, Canada and Australia. Earlier, in his opening speech, Dr Dzulkefly said introducing DRG in phases to pay for healthcare services, beginning with the base medical and health insurance/takaful products, would be a key driver for value-based healthcare. He also said the Health Ministry is hoping to introduce the DRG payment model by the end of 2025.
